GSK6853 is primarily utilized in the field of biomedical research, particularly in the study of cancer. It functions as a potent and selective inhibitor of the protein kinase DYRK1A, which plays a significant role in cell proliferation and survival. Researchers employ GSK6853 to investigate the molecular mechanisms underlying various diseases, including certain types of leukemia and solid tumors. By inhibiting DYRK1A, this compound helps in understanding the pathways involved in cancer progression and aids in the development of targeted therapeutic strategies. Additionally, GSK6853 is used in preclinical studies to evaluate its potential efficacy and safety as a candidate for anticancer drug development. Its application extends to exploring its effects on neurodevelopmental disorders, given the involvement of DYRK1A in brain function and development.